Literature DB >> 14642144

A comparative study of clinical manifestations caused by tuberculosis in immunocompromised and non-immunocompromised patients.

Changzhou Shao1, Jieming Qu, Lixian He.   

Abstract

OBJECTIVE: To characterize the differences between clinical manifestations in immunocompromised patients (ICPs) and non-immunocompromised patients (non-ICPs) with tuberculosis.
METHODS: Underlying diseases, clinical presentations, misdiagnosis, treatment and prognosis, etc, were analyzed retrospectively in 115 tuberculosis patients, including 39 ICPs and 76 non-ICPs.
RESULTS: Compared with non-ICPs, the individuals who were ICP had more expectoration (64.1% vs 35.5%), pulmonary moist rale (41.0% vs 9.2%), miliary pulmonary tuberculosis (30.8% vs 2.6%), pleural effusion (48.7% vs 25.0%) and lymphadenopathy (18.0% vs 4.0%). ICPs had less lung cavity (15.4% vs 22.4%) and pleural thickening (15.4% vs 23.7%) compared to non-ICPs. Pulmonary tuberculosis in ICPs was prone to be misdiagnosed as pneumonia (23.1% vs 6.6%). Pulmonary tuberculosis was found in the apicoposterior segment (SI + SII) in more cases in non-ICPs (21.7%, 10/46) than ICPs (10.3%, 3/29). The diagnostic value of tuberculin skin test and adenosine deaminase in pleural effusions was limited in ICPs. ICPs had significantly poorer prognoses than non-ICPs.
CONCLUSION: The clinical manifestations of ICPs with tuberculosis are atypical, misdiagnosis often occurs, resulting in a worse prognosis.

Entities:  

Mesh:

Year:  2003        PMID: 14642144

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  5 in total

1.  Diagnosis and management of miliary tuberculosis: current state and future perspectives.

Authors:  Sayantan Ray; Arunansu Talukdar; Supratip Kundu; Dibbendhu Khanra; Nikhil Sonthalia
Journal:  Ther Clin Risk Manag       Date:  2013-01-08       Impact factor: 2.423

Review 2.  Challenges in the diagnosis & treatment of miliary tuberculosis.

Authors:  Surendra K Sharma; Alladi Mohan; Abhishek Sharma
Journal:  Indian J Med Res       Date:  2012-05       Impact factor: 2.375

Review 3.  Miliary tuberculosis: A new look at an old foe.

Authors:  Surendra K Sharma; Alladi Mohan; Animesh Sharma
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2016-03-18

4.  Encephalitis due to miliary tuberculosis in a patient with human immunodeficiency virus: A case report.

Authors:  Rizaldy Taslim Pinzon; Vincent Ongko Wijaya; Dessy Paramitha
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-03-19

5.  Treatment response and adverse reactions in older tuberculosis patients with immunocompromising comorbidities.

Authors:  Seo Yun Kim; Sang-Min Lee; Jae-Joon Yim; Chul-Gyu Yoo; Young Whan Kim; Sung Koo Han; Seok-Chul Yang
Journal:  Yonsei Med J       Date:  2013-09       Impact factor: 2.759

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.